ArticleJournal of surgical case reports2025
Splenic metastasis from small bowel adenocarcinoma.
Article in Journal of surgical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Small bowel adenocarcinoma is a rare malignancy, often diagnosed at advanced stages due to nonspecific symptoms. Common metastatic sites include the liver and peritoneum, while splenic involvement has not been previously documented. We report the case of a 42-year-old woman with chronic anemia and dyspepsia, who later presented with overt gastrointestinal bleeding. Imaging revealed a stenotic jejunal lesion, hypermetabolic mesenteric lymphadenopathy, and a hypermetabolic splenic nodule on positron emission tomography-computed tomography (PET/CT). She underwent laparoscopic segmental jejunal resection with lymphadenectomy, followed by laparoscopic splenectomy. Histopathology confirmed a moderately differentiated adenocarcinoma with nodal involvement (pT3 pN2) and an enteric-type adenocarcinoma infiltrating the spleen. The patient recovered uneventfully and is scheduled for adjuvant chemotherapy. This case highlights the diagnostic challenges of small bowel adenocarcinoma, the role of PET/CT in staging, and the feasibility of laparoscopic splenectomy for rare isolated splenic metastases. Long-term follow-up will determine its prognostic impact.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.